- Home
- IRMD vs PCN Comparison
IRMD vs PCN Comparison
Compare IRMD & PCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- PCN
- Stock Information
- Founded
- IRMD 1992
- PCN 2001
- Country
- IRMD United States
- PCN United States
- Employees
- IRMD N/A
- PCN N/A
- Industry
- IRMD Medical/Dental Instruments
- PCN Investment Managers
- Sector
- IRMD Health Care
- PCN Finance
- Exchange
- IRMD Nasdaq
- PCN Nasdaq
- Market Cap
- IRMD 618.5M
- PCN 728.5M
- IPO Year
- IRMD 2014
- PCN N/A
- Fundamental
- Price
- IRMD $51.99
- PCN $13.90
- Analyst Decision
- IRMD Strong Buy
- PCN
- Analyst Count
- IRMD 1
- PCN 0
- Target Price
- IRMD $60.00
- PCN N/A
- AVG Volume (30 Days)
- IRMD 36.4K
- PCN 218.7K
- Earning Date
- IRMD 10-31-2024
- PCN 01-01-0001
- Dividend Yield
- IRMD 1.15%
- PCN 9.73%
- EPS Growth
- IRMD 13.16
- PCN N/A
- EPS
- IRMD 1.46
- PCN N/A
- Revenue
- IRMD $71,305,130.00
- PCN N/A
- Revenue This Year
- IRMD $13.29
- PCN N/A
- Revenue Next Year
- IRMD $10.76
- PCN N/A
- P/E Ratio
- IRMD $35.61
- PCN N/A
- Revenue Growth
- IRMD 13.23
- PCN N/A
- 52 Week Low
- IRMD $40.05
- PCN $10.70
- 52 Week High
- IRMD $57.95
- PCN $14.48
- Technical
- Relative Strength Index (RSI)
- IRMD 48.18
- PCN 51.59
- Support Level
- IRMD $55.40
- PCN $13.78
- Resistance Level
- IRMD $57.95
- PCN $13.93
- Average True Range (ATR)
- IRMD 2.33
- PCN 0.09
- MACD
- IRMD -0.04
- PCN 0.01
- Stochastic Oscillator
- IRMD 46.26
- PCN 52.63
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About PCN Pimco Corporate & Income Strategy Fund
PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income. The secondary investment objective of the fund is capital preservation and appreciation. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.